CID 0805 - Treatment of Acute HIV Infection With a Once Daily Regimen of Emtricitabine, Tenofovir and Efavirenz - A Pilot Study of Response to Therapy and HIV Pathogenesis.
Phase of Trial: Phase IV
Latest Information Update: 22 May 2017
At a glance
- Drugs Efavirenz/emtricitabine/tenofovir-disoproxil-fumarate (Primary)
- Indications HIV infections
- Focus Therapeutic Use
- 10 Jun 2017 Biomarkers information updated
- 10 Sep 2014 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 04 Sep 2013 Planned end date changed from 1 Dec 2014 to 1 Dec 2013 as reported by ClinicalTrials.gov.